The drug Avandia which is a Type II diabetes drug is raising concerns in medical quarters in the United Kingdom and the USA – see report. The drug is under review across Europe having been linked to a raised risk of heart attacks and heart failure. The respected UK Medicines and Healthcare products Regulatory Agency’s (MHRA) has recommended suspension of the drug but it alarmingly remains available to the public in the United Kingdom. To be expected the pharmaceutical company GlaxoSmithKline who manufacturers Avandia insists the drug is safe if properly monitored, as its research programme has shown it to be ‘safe and effective when it is prescribed appropriately. The European Medicines Agency (EMA) is expected to announce later this month whether Avandia should be restricted, or withdrawn completely. In the USA similar concerns are being voiced.
Although the drug is not widely stocked by pharmacies in Barbados there is limited use and we hope the health authorities are following the Avandia story.
The blogmaster invites you to join the discussion.